Skip to main content
. 2006 Aug;80(15):7439–7449. doi: 10.1128/JVI.00576-06

TABLE 3.

SPR results for binding of chemokines to mutant EVM1

EMV1 variant Binding parameters for hCCL3a
Affinity for hCCL2 (KDb [nM])
ka (106M−1s−1) kd (10−4s−1) KD (pM) KD (mut)/KD (wt) t1/2 (min)
WT 12 ± 4 3.4 ± 0.6 29 ± 11 34 44 ± 2
E17R 15 ± 3 4 ± 1 26 ± 12 0.9 29 NDc
E60R 7 ± 1 4 ± 1 57 ± 18 2 29 ND
Y69R 9 ± 1 140 ± 20 1,500 ± 300 52 0.8 >1,000
T84R 9 ± 1 4.2 ± 0.4 49 ± 9 1.7 28 ND
L125R 22 ± 8 4 ± 1 18 ± 8 0.6 29 ND
S134R 6 ± 1 7.0 ± 0.8 130 ± 30 4 17 500 ± 30
N136W 5 ± 1 7 ± 1 140 ± 40 5 17 240 ± 20
K138Y 5 ± 1 1.3 ± 0.4 25 ± 8 0.9 89 ND
S171W 18 ± 3 130 ± 20 720 ± 160 24 0.9 >1,000
S171Y 17 ± 2 390 ± 50 2,300 ± 400 79 0.3 >1,000
I173Y 12 ± 2 310 ± 20 2,600 ± 500 90 0.4 >1,000
I173R 3.5 ± 0.7 470 ± 60 13,000 ± 3,000 448 0.3 >1,000
Δ51-65 2.2 ± 0.6 230 ± 30 10,000 ± 3,000 344 0.5 >1,000
a

Values for ka, kd, and KD are means ± standard deviations. KD = kd/ka; t1/2 = 0.693/kd.

b

KD from equilibrium binding analysis.

c

ND indicates measurements that were not determined.